BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8704030)

  • 1. Analysis of the in vitro secretory activity of human pituitary adenomas: modification of corticotropin release from adenoma tissue explant cultures by addition of a human plasma ultrafiltrate bioactive fraction.
    Zarković N; Hayn M; Plavsić V; Zarković K; Paladino J; Hirsl N; Golubić J; Mikulandra S; Rogić D; Salzer B; Pokrić B; Schaur RJ; Tatzber F; Faulhammer H; Benko B; Dietrich W; Jurin M; Korsić M
    Eur J Clin Chem Clin Biochem; 1996 Jan; 34(1):23-30. PubMed ID: 8704030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth promoting effect of human plasma ultrafiltrate bioactive fraction (TBP) for human non-functioning pituitary adenoma cells in vitro.
    Zarković N; Hayn M; Tatzber F; Reichel H; Kor ić M; Zarković K; Plav ić V; Breskovac LJ; Klingmüller M; Paladino J
    J Endocrinol Invest; 2000 Dec; 23(11):737-43. PubMed ID: 11194707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The release of leptin and its effect on hormone release from human pituitary adenomas.
    Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
    Heaney AP; Curry WJ; Pogue KM; Armstrong VL; Mirakhur M; Sheridan B; Johnston CF; Buchanan KD; Atkinson AB
    Pituitary; 2000 Oct; 3(2):67-75. PubMed ID: 11141698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7B2, a new protein secreted by human functionless pituitary tumours, in vitro.
    Venetikou MS; Ghatei MA; Burrin JM; Latif S; Bloom SR
    Acta Endocrinol (Copenh); 1988 Aug; 118(4):521-7. PubMed ID: 3400405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 stimulates the release of interleukin-6 from cultured human pituitary adenoma cells.
    Jones TH; Kennedy RL; Justice SK; Price A
    Acta Endocrinol (Copenh); 1993 May; 128(5):405-10. PubMed ID: 8391194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
    Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
    Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
    Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium.
    Lipson LG; Beitins IZ; Kornblith PL; McArthur JW; Friesen HG; Kliman B; Kjellberg RN
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):421-33. PubMed ID: 218413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to corticotrophin-releasing hormone and dexamethasone in a large series of human adrenocorticotrophic hormone-secreting pituitary adenomas in vitro reveal manifold corticotroph tumoural phenotypes.
    Pecori Giraldi F; Pagliardini L; Cassarino MF; Losa M; Lasio G; Cavagnini F
    J Neuroendocrinol; 2011 Dec; 23(12):1214-21. PubMed ID: 21883533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.
    Westphal M; Jaquet P; Wilson CB
    Acta Neuropathol; 1986; 71(1-2):111-8. PubMed ID: 3022531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
    Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
    J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells.
    Lamberts SW; Bons EG; Uitterlinden P
    Acta Endocrinol (Copenh); 1985 May; 109(1):64-9. PubMed ID: 2988258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
    van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; Mol JA
    Eur J Endocrinol; 1998 Mar; 138(3):309-15. PubMed ID: 9539306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.